Fate Therapeutics, Inc.

Fate Therapeutics, Inc.

$1.35
0.09 (0%)
FATE
NASDAQ Global Market
USD, US
Biotechnology
Product SegmentationGeographic Segmentation

Revenue Segmentation by geographic